TrialAmerican journal of ophthalmology2022

Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion.

Ingrid U Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.